SCHEMBL459047

SCHEMBL459047

Cc1cc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)no1.N#Cc1cc(-c2ccnc(Nc3ncc(C(N)=O)o3)n2)ccc1N1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 11/20 0.49
IKBKE Q14164 8/20 0.49
CDC7 O00311 1/20 0.38
ROCK2 O75116 1/20 0.38
MAP4K4 O95819 1/20 0.38
CDK2 P24941 1/20 0.38
GSK3B P49841 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
MAP3K14 Q99558 3/20 0.37
JAK2 O60674 4/20 0.37
JAK3 P52333 2/20 0.37
NEK3 P51956 1/20 0.35
LIMK1 P53667 1/20 0.35
NEK5 Q6P3R8 1/20 0.35
MYLK4 Q86YV6 1/20 0.35
STK17A Q9UEE5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080689 0.92 TBK1 (0.53) TBK1IKBKECDC7ROCK2MAP4K4
SCHEMBL10080741 0.87 TBK1 (0.61) TBK1IKBKECDK2MAP3K14JAK2
SCHEMBL10080744 0.84 TBK1 (0.54) TBK1IKBKEMAP3K14JAK2JAK3
SCHEMBL15307921 0.82 TBK1 (0.49) TBK1IKBKEMAP3K14JAK2JAK3
SCHEMBL16667407 0.80 TBK1 (0.51) TBK1IKBKECDC7ROCK2MAP4K4
SCHEMBL10080690 0.77 TBK1 (0.53) TBK1IKBKECDC7ROCK2MAP4K4
SCHEMBL10080362 0.76 TBK1 (0.53) TBK1IKBKECDC7ROCK2MAP4K4
SCHEMBL433909 0.76 TBK1 (0.53) TBK1CDC7ROCK2MAP4K4CDK2
SCHEMBL433957 0.75 TBK1 (0.63) TBK1IKBKEROCK2CDK2GSK3B
SCHEMBL16684089 0.74 TBK1 (0.54) TBK1IKBKECDK2MAP3K14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595964-A1 PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Domainex Limited (GB) 2013-05-29 EP claimed
WO-2012010826-A1 PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMAINEX LIMITED (GB) 2012-01-26 WO claimed
EP-2595964-A1 PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Domainex Limited (GB) 2013-05-29 EP disclosed
WO-2012010826-A1 PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMAINEX LIMITED (GB) 2012-01-26 WO disclosed